In order to strengthen the functions of the Board of Directors and the internal control mechanism, the Company has set up an Audit Committee. The Audit Committee is composed of all independent directors and holds meetings at least once a quarter. In addition, the “Organizational Regulations of Audit Committee” have been formulated, and its functions and powers are stipulated as follows:

• Adoption of or amendments of an internal control system pursuant to Article 14-1 of the Securities and Exchange Act.
• Assessment of the effectiveness of the internal control system.
• Adoption or amendment, pursuant to Article 36-1 of the Securities and Exchange Act, of the procedures for handling financial or business activities of a material nature, such as acquisition or disposal of assets, derivatives trading, loaning of funds to others, and endorsements or guarantees for others.
• A matter bearing on the personal interest of a director.
• Asset transactions or derivatives trading of a material nature.
• Loans of funds, endorsements, or provision of guarantees of a material nature.
• The offering, issuance, or private placement of equity-type securities.
• The hiring or dismissal of the attesting certified public accountant, or their compensation.
• The appointment or discharge of a financial, accounting, or internal audit officer.
• Annual financial reports signed or sealed by the President, manager and accounting officer, and financial reports of the second quarter audited and reviewed by CPAs.
• Other material matters as may be required by the Company or by the competent authority.

 

Annual priorities of the Audit Committee of the year

• Fair presentation of the financial reports of the Corporation.
• The effective implementation of the internal control system of the Corporation.
• Compliance with relevant laws and regulations by this Corporation.
• Control of the existing or potential risks of this Corporation.
• Other material matters as may be required by the Company or by the competent authority and the Corporation.

 

Members of Audit Committee

Title	Name	Academic Background	Work Experiences	Current Position
Independent Director	Convenor YANG, YU-PING	MBA, National Taipei University	Audit Senior Manager, Ernst & Young Manager of Administration Department, Eon Silicon Solution Inc. Audit Senior Manager, Deloitte Taiwan	Deputy general manager of Finance and Accounting Department, Medigen Vaccine Biologics Corporation Independent Director, YE FONG ALUMINIUM INDUSTRIAL LTD. Supervisor, Thermolysis Co., Ltd.
Independent Director	CHAN, HOU-SHENG	Institute of Social Administration, University of Wales, UK	Professor and Chair, NTU Department of Sociology Professor and Dean, CCU Graduate Institute of Social Welfare	Emeritus Professor, National Chi Nan University President, Cross-Starit Common Market Foundation Director, CTCI Advanced Systems Inc.
Independent Director	LIU, HUI-CHUN	Department of Law, National Taiwan University	Supervisor, CyberTAN Technology, Inc. Bankruptcy Trustee, Chunghwa Picture Tubes, Ltd.	Lawyer in charge of A&P Law Offices Restructuring Supervisor, Wintek Corporation Liquidator, Keguan Energy Technology Co., Ltd. Bankruptcy Administrator, Chunghwa Picture Tubes Co., Ltd. Independent Director, CyberTAN Technology Inc. Independent Director, Pacific Construction Co., Ltd. Supervisor, Geor Chi Electronics Co., Ltd.
Independent Director	WU, CHIN-WEN	Ph.D. of Institute of Finance, National Kaohsiung First University of Science and Technology	MA, Taipei Fubon Commercial Bank Co., Ltd. Assistant Professor of Department of Finance, Nanhua University	Associate Professor of Department of Finance, Nanhua University

 

Meeting Count for 2nd-Term Members (As of Q2)